Diabetes researcher Dr. Antonio Ceriello has been named medical director of Finnish company Mendor.
Currently Professor Ceriello is head of the Research Department on Diabetes and CVD at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain and is the president of the European Association for the Study of Diabetes Study Group on “Diabetes and Cardiovascular Diseases.”
Ceriello has published widely in the area of diabetes with more than 350 original papers and several book chapters to his name. He has been a consultant of the National Institutes of Health, U.S., for a research program in 2003-2005 related to cardiovascular disease and type 1 diabetes, and was a member of the writing committee of the American Heart Association for “Acute Hyperglycemia and Acute Coronary Syndromes.”
“Mendor is one of the most advanced companies in the field of health technology, offering very advanced solutions for the management of diabetes,” Ceriello said. “These solutions can make a difference for health care professionals and people with diabetes in managing this challenging disease. I am very glad to offer my experience to such a dynamic company in order to further progress to find even better solutions enabling improvement, worldwide, of the life of people with diabetes.”